A Banner Year for New Drugs


Xconomy Boston — 

[Editor’s note: To tap the wisdom of our distinguished group of Xconomists, we asked a few of them to answer this question heading into 2013: “What does your gut tell you will happen this year even though you don’t have data to prove it?”]

I think there will be even more FDA approvals for New Molecular Entities in 2013 compared with 2012 and 2011, which have been “banner years” for approvals. Why? Industry has stepped up their game on innovative medicines and the FDA has now set a better balance of risk and benefit.


By posting a comment, you agree to our terms and conditions.

One response to “A Banner Year for New Drugs”